A detailed history of Black Rock Inc. transactions in Biote Corp. stock. As of the latest transaction made, Black Rock Inc. holds 1,605,028 shares of BTMD stock, worth $9.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,605,028
Previous 972,834 64.98%
Holding current value
$9.79 Million
Previous $5.64 Million 112.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.44 - $7.47 $3.44 Million - $4.72 Million
632,194 Added 64.98%
1,605,028 $12 Million
Q1 2024

May 10, 2024

BUY
$3.79 - $6.91 $898 - $1,637
237 Added 0.02%
972,834 $5.64 Million
Q4 2023

Feb 13, 2024

BUY
$4.43 - $5.81 $1.05 Million - $1.38 Million
237,650 Added 32.34%
972,597 $4.8 Million
Q3 2023

Nov 13, 2023

BUY
$4.73 - $7.83 $656,836 - $1.09 Million
138,866 Added 23.3%
734,947 $3.76 Million
Q2 2023

Aug 11, 2023

BUY
$5.27 - $6.9 $3.14 Million - $4.11 Million
596,081 New
596,081 $4.03 Million

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $46.2M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.